Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Cash Flow Reinvestment Rate
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Cash Flow Reinvestment Rate of 0.19x as of September 2025, reinvesting CN¥54.40 Million (capex CN¥54.40 Million ) from operating cash flow of CN¥281.88 Million. Explore Shaanxi Meibang Pharmaceutical Group Co (605033) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shaanxi Meibang Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Shaanxi Meibang Pharmaceutical Group Co Ltd across 7 annual periods. Also explore 605033 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Year-by-year capital reinvestment analysis for Shaanxi Meibang Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see market cap of Shaanxi Meibang Pharmaceutical Group Co .
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.92x | CN¥539.05 Million | CN¥280.40 Million | CN¥158.81 Million | ▲ +123.3% |
| 2023 | 0.86x | CN¥288.20 Million | CN¥334.79 Million | CN¥203.69 Million | ▼ -24.3% |
| 2022 | 1.14x | CN¥143.69 Million | CN¥126.41 Million | CN¥109.29 Million | ▼ -19.1% |
| 2020 | 1.40x | CN¥105.20 Million | CN¥74.88 Million | CN¥61.71 Million | ▲ +218.4% |
| 2019 | 0.44x | CN¥56.69 Million | CN¥128.45 Million | CN¥33.78 Million | ▼ -78.5% |
| 2018 | 2.06x | CN¥34.86 Million | CN¥16.96 Million | CN¥34.86 Million | ▲ +244.2% |
| 2017 | 0.60x | CN¥17.56 Million | CN¥29.41 Million | CN¥17.56 Million | — |